Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata references "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2002.
Business Overview: The Company provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of March 31, 2002, operations included approximately 1,900 locations across 50 states and international markets.
Key Financial Metrics
| Metric (in thousands) | Q1 2002 | Q1 2001 |
|---|---|---|
| Revenues | $1,129,775 | $1,090,462 |
| Net Income | $107,749 | $75,311 |
| Diluted EPS | $0.27 | $0.19 |
| Operating Cash Flow | $200,862 | $80,196 |
| Long-Term Debt | $2,997,129 | $3,005,035 |
| Cash and Equivalents | $236,178 | $181,677 |
| Working Capital | $1,360,108 | N/A |
Margins: Operating expenses (excluding corporate G&A, bad debt, D&A, and interest) were 65.2% of revenues in Q1 2002, compared to 67.5% in Q1 2001. The effective tax rate was 38.75%.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 3.6% ($39.3 million) year-over-year, driven primarily by increased patient volumes. Same-store revenues increased 8.8%.
- Profitability: Net income increased 43% ($32.4 million) due to revenue growth, reduced operating expense ratios, and lower interest expense.
- Interest Expense: Decreased significantly to $48.0 million from $59.4 million, attributed to lower effective interest rates.
- Depreciation & Amortization: Decreased to $77.6 million from $91.2 million, primarily due to the adoption of SFAS No. 142 (Goodwill and Other Intangibles), which eliminated monthly amortization of goodwill.
- Cash Flow: Operating cash flow more than doubled to $200.9 million, largely due to a significant reduction in accounts payable in the prior year's first quarter.
- Capital Expenditures: Investing cash outflows increased to $217.0 million (from $127.3 million) due to accelerated development activities and facility expansions.
Outlook, Risks, and Management Commentary
- Medicare PPS Transition: The Company transitioned to a Prospective Payment System (PPS) for inpatient rehabilitation services on January 1, 2002. Management believes early experience is consistent with internal estimates and expects a positive effect on operations, though final impacts remain uncertain.
- Capital Allocation: The Company anticipates spending $150 million to $200 million on maintenance/expansion and $300 million to $350 million on development activities over the next 12 months.
- Debt Maturity: The $1.75 billion revolving credit facility matures in June 2003. Management is in the process of securing a replacement facility, expected by the end of Q2 2002.
- Legal Proceedings:
- Securities Litigation: Consolidated class action lawsuits regarding alleged misrepresentations (1997-1998) remain pending. A hearing on class certification was held in April 2002; a ruling is not expected until Q3 2002.
- False Claims Act: The Department of Justice partially intervened in a qui tam case alleging Medicare violations regarding physical therapy practices. The DOJ withdrew intervention in one case on May 8, 2002, citing earlier-filed cases. The Company expects to vigorously defend against these claims.
- Accounting Changes: Adoption of SFAS No. 142 and SFAS No. 144 (Impairment of Long-Lived Assets) on January 1, 2002. Management is currently evaluating goodwill for impairment under the new standard.
Investor Verification Checklist
- PPS Impact: Verify if the transition to Medicare Prospective Payment System continues to yield the projected positive financial results as implementation matures.
- Legal Exposure: Monitor the status of the consolidated securities litigation and the False Claims Act investigations, as outcomes could result in material liabilities.
- Debt Refinancing: Confirm the successful execution of the replacement credit facility before the June 2003 maturity of the current $1.75 billion revolver.
- Goodwill Impairment: Review future filings for the results of the SFAS No. 142 goodwill impairment testing, which could materially affect reported earnings.
- Receivables Aging: Note the increase in days sales outstanding (from 77.6 to 81.5 days) attributed to Medicare fiscal intermediary delays; monitor if this trend persists.